本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Acrivon Therapeutics, Inc.

1.40
-0.0400-2.78%
盤前1.500.1000+7.14%08:22 EDT
成交量:91.54萬
成交額:131.71萬
市值:4,389.21萬
市盈率:-0.59
高:1.55
開:1.43
低:1.40
收:1.44
資料載入中...
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

重要事件披露

Form 8-K - Current report
2023/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/09

重要事件披露

Form 8-K - Current report
2023/05/01

重要事件披露

Form 8-K - Current report
2023/05/01

重要事件披露

Form 8-K - Current report
2023/04/25

重要事件披露

Form 8-K - Current report
2023/03/30

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/03/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/03/28

重要事件披露

Form 8-K - Current report
2023/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

Form 8-K - Current report
2023/03/03

重要事件披露

Form 8-K - Current report
2023/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2022/12/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/28

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals